Clinical Trial Update: Novel Targeted Radiotherapy in Pediatric Patients With Inoperable Relapsed or Refractory HGG [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial update for a novel targeted radiotherapy in pediatric patients with inoperable relapsed or refractory high-grade glioma. The st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• High-grade Glioma

Snippet

Sponsor: Cellectar Biosciences, Inc. | Conditions: High-Grade Glioma | Phase 1 | Status: ACTIVE_NOT_RECRUITING